Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$417,899
in 3 filings, $395K under 10b5-1 plans

Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. LEONARD JOHN M −$395K President and CEO sold 3% of stake
  2. Dube Michael P −$23K VP, Chief Accounting Officer sold 3% of stake

Reading 7 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-02 LEONARD JOHN M President and CEO Sale 10b5-1 −9,000 $11.99 $108K 1,138,064
2026-10-26 Marantz Jing L. EVP, Chief Medical Officer Grant or award +199,822 199,822
2026-10-26 Marantz Jing L. EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +275,061 275,061
2026-10-02 Dube Michael P VP, Chief Accounting Officer Sale −1,864 $12.43 $23K 65,022
2026-08-21 LEONARD JOHN M President and CEO Sale 10b5-1 −2,785 $13.00 $36K 1,147,064
2026-08-20 LEONARD JOHN M President and CEO Sale 10b5-1 −19,890 $12.60 $251K 1,149,849
2026-07-22 Dulac Edward J III EVP, Chief Financial Officer Sale −8,111 $11.25 $91K 148,175
2026-07-02 Dulac Edward J III EVP, Chief Financial Officer Sale 10b5-1 −4,677 $18.00 $84K 156,286
2026-07-01 Dube Michael P VP, Chief Accounting Officer Sale −2,641 $16.78 $44K 66,886
2026-06-09 GOODMAN JESSE Director Grant or award +9,200 33,559
2026-06-09 GOODMAN JESSE Director Grant or award · Stock Option (right to buy) +13,300 13,300
2026-06-09 CHASE WILLIAM J Director Grant or award +9,200 143,893
2026-06-09 CHASE WILLIAM J Director Grant or award · Stock Option (right to buy) +13,300 13,300
2026-06-09 Verwiel Frank Director Grant or award +9,200 35,148
2026-06-09 Verwiel Frank Director Grant or award · Stock Option (right to buy) +13,300 13,300
2026-06-09 Keresty Georgia Director Grant or award +9,200 41,083
2026-06-09 Keresty Georgia Director Grant or award · Stock Option (right to buy) +13,300 13,300
2026-06-09 Goff Brian Director Grant or award +9,200 32,609
2026-06-09 Goff Brian Director Grant or award · Stock Option (right to buy) +13,300 13,300
2026-06-09 Cohen Fred E Director Grant or award +9,200 216,653

Page 1 of 40 · 783 trades